{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:35:19Z","timestamp":1793378119761,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.rmed.2026.109006","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T23:09:09Z","timestamp":1782774549000},"page":"109006","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeting the neutrophil\u2013DPP-1\u2013protease axis in airway disease: current evidence and future indications"],"prefix":"10.1016","volume":"261","author":[{"given":"Luigi","family":"Pastorino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Ferraris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2664-327X","authenticated-orcid":false,"given":"Michela","family":"Robbiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Staffiere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Riccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulvio","family":"Braido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.rmed.2026.109006_bib1","doi-asserted-by":"crossref","first-page":"e571","DOI":"10.7861\/clinmed.2021-0651","article-title":"Diagnosis and management of non-cystic fibrosis bronchiectasis","volume":"21","author":"Macfarlane","year":"2021","journal-title":"Clin. Med."},{"issue":"5","key":"10.1016\/j.rmed.2026.109006_bib2","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/path.5364","article-title":"Recent advances in chronic obstructive pulmonary disease pathogenesis: from disease mechanisms to precision medicine","volume":"250","author":"Brandsma","year":"2020","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.rmed.2026.109006_bib3","first-page":"1034","article-title":"Neutrophil dysfunction in bronchiectasis: pathophysiological insights and emerging targeted therapies","volume":"20","author":"Taha","year":"2025","journal-title":"Multidiscip Respir Med"},{"issue":"1","key":"10.1016\/j.rmed.2026.109006_bib4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12931-023-02444-z","article-title":"Dipeptidyl peptidase-1 inhibition with brensocatib reduces the activity of all major neutrophil serine proteases in patients with bronchiectasis: results from the WILLOW trial","volume":"24","author":"Cipolla","year":"2023","journal-title":"Respir. Res."},{"issue":"15","key":"10.1016\/j.rmed.2026.109006_bib5","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1111\/bph.13515","article-title":"Neutrophil maturation rate determines the effects of dipeptidyl peptidase 1 inhibition on neutrophil serine protease activity","volume":"173","author":"Gardiner","year":"2016","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.rmed.2026.109006_bib6","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01551-2024","article-title":"Cathepsin C (dipeptidyl peptidase 1) inhibition in adults with bronchiectasis: AIRLEAF, a phase II randomised, double-blind, placebo-controlled, dose-finding study","volume":"65","author":"Chalmers","year":"2025","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.rmed.2026.109006_bib7","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03157-2020","article-title":"Neutrophil dysfunction in bronchiectasis: an emerging role for immunometabolism","volume":"58","author":"Giam","year":"2021","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.rmed.2026.109006_bib8","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4103\/0972-124X.75919","article-title":"Haim-munk syndrome","volume":"14","author":"Pahwa","year":"2010","journal-title":"J. Indian Soc. Periodontol."},{"issue":"12","key":"10.1016\/j.rmed.2026.109006_bib9","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/jmg.36.12.881","article-title":"Mutations of the cathepsin C gene are responsible for papillon-lef\u00e8vre syndrome","volume":"36","author":"Hart","year":"1999","journal-title":"J. Med. Genet."},{"issue":"5","key":"10.1016\/j.rmed.2026.109006_bib10","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3390\/antiox11050965","article-title":"Oxidative stress in chronic obstructive pulmonary disease","volume":"11","author":"Barnes","year":"2022","journal-title":"Antioxidants"},{"issue":"8","key":"10.1016\/j.rmed.2026.109006_bib11","doi-asserted-by":"crossref","first-page":"472","DOI":"10.21037\/atm-22-1480","article-title":"Abnormal neutrophil polarization in chronic obstructive pulmonary disease and how cigarette smoke extracts attract neutrophils","volume":"10","author":"Deng","year":"2022","journal-title":"Ann. Transl. Med."},{"issue":"2","key":"10.1016\/j.rmed.2026.109006_bib12","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jaci.2025.04.011","article-title":"Innate immune reprogramming in circulating neutrophils of COPD patients","volume":"156","author":"Mariotti","year":"2025","journal-title":"J. Allergy Clin. Immunol."},{"issue":"11","key":"10.1016\/j.rmed.2026.109006_bib13","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S2213-2600(23)00261-8","article-title":"COPD and multimorbidity: recognising and addressing a syndemic occurrence","volume":"11","author":"Fabbri","year":"2023","journal-title":"Lancet Respir. Med."},{"issue":"9410","key":"10.1016\/j.rmed.2026.109006_bib14","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0140-6736(04)15650-X","article-title":"Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase","volume":"363","author":"Barnes","year":"2004","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.rmed.2026.109006_bib15","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1172\/JCI0213462","article-title":"Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis","volume":"109","author":"Adkison","year":"2002","journal-title":"J. Clin. Investig."},{"issue":"7","key":"10.1016\/j.rmed.2026.109006_bib16","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nri1841","article-title":"Neutrophil serine proteases: specific regulators of inflammation","volume":"6","author":"Pham","year":"2006","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.rmed.2026.109006_bib17","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nm.2678","article-title":"Asthma phenotypes: the evolution from clinical to molecular approaches","volume":"18","author":"Wenzel","year":"2012","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.rmed.2026.109006_bib18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nri3786","article-title":"Type 2 inflammation in asthma--present in Most, absent in many","volume":"15","author":"Fahy","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.rmed.2026.109006_bib19","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jaci.2017.12.1009","article-title":"Refractory airway type 2 inflammation in a large subgroup of asthmatic patients treated with inhaled corticosteroids","volume":"143","author":"Peters","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"issue":"12","key":"10.1016\/j.rmed.2026.109006_bib20","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.it.2017.07.003","article-title":"Neutrophilic inflammation in asthma and association with disease severity","volume":"38","author":"Ray","year":"2017","journal-title":"Trends Immunol."},{"issue":"4","key":"10.1016\/j.rmed.2026.109006_bib21","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0091-6749(95)70128-1","article-title":"Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation","volume":"95","author":"Fahy","year":"1995","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.rmed.2026.109006_bib22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1440-1843.2006.00784.x","article-title":"Inflammatory subtypes in asthma: assessment and identification using induced sputum","volume":"11","author":"Simpson","year":"2006","journal-title":"Respirology"},{"issue":"7","key":"10.1016\/j.rmed.2026.109006_bib23","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/thorax.57.7.643","article-title":"Non-eosinophilic asthma: importance and possible mechanisms","volume":"57","author":"Douwes","year":"2002","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.rmed.2026.109006_bib24","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02135-2016","article-title":"T-helper cell type 2 (Th2) and non-Th2 molecular phenotypes of asthma using sputum transcriptomics in U-BIOPRED","volume":"49","author":"Kuo","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.rmed.2026.109006_bib25","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1164\/rccm.201810-1944CI","article-title":"Role of biologics in asthma","volume":"199","author":"McGregor","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.rmed.2026.109006_bib26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1248\/bpb.b19-00095","article-title":"Steroid-resistant asthma and neutrophils","volume":"43","author":"Nabe","year":"2020","journal-title":"Biol. Pharm. Bull."},{"issue":"1\u20132","key":"10.1016\/j.rmed.2026.109006_bib27","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cell.2017.11.034","article-title":"Modulation of myelopoiesis progenitors is an integral component of trained immunity","volume":"172","author":"Mitroulis","year":"2018","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.rmed.2026.109006_bib28","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.smim.2016.09.002","article-title":"Immunometabolic circuits in trained immunity","volume":"28","author":"Arts","year":"2016","journal-title":"Semin. Immunol."},{"issue":"6","key":"10.1016\/j.rmed.2026.109006_bib29","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","article-title":"Defining trained immunity and its role in health and disease","volume":"20","author":"Netea","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.rmed.2026.109006_bib30","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1365-2222.2012.04014.x","article-title":"Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo-controlled clinical trial","volume":"42","author":"Nair","year":"2012","journal-title":"Clin. Exp. Allergy"},{"issue":"6","key":"10.1016\/j.rmed.2026.109006_bib31","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1111\/bcp.12724","article-title":"The effect of a selective CXCR2 antagonist (AZD5069) on human blood neutrophil count and innate immune functions","volume":"80","author":"Jurcevic","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"10","key":"10.1016\/j.rmed.2026.109006_bib32","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1164\/rccm.201405-0859PP","article-title":"IL-17 in severe asthma. Where do we stand?","volume":"190","author":"Chesn\u00e9","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"11","key":"10.1016\/j.rmed.2026.109006_bib33","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1164\/rccm.201212-2318OC","article-title":"Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma","volume":"188","author":"Busse","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.rmed.2026.109006_bib34","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.rmed.2012.12.009","article-title":"Phase II study of a neutrophil elastase inhibitor (AZD9668) in patients with bronchiectasis","volume":"107","author":"Stockley","year":"2013","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2026.109006_bib35","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.pupt.2019.03.009","article-title":"Safety and efficacy of the human neutrophil elastase inhibitor BAY 85-8501 for the treatment of non-cystic fibrosis bronchiectasis: a randomized controlled trial","volume":"56","author":"Watz","year":"2019","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.rmed.2026.109006_bib36","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1183\/13993003.00148-2015","article-title":"A randomised, placebo-controlled study of the CXCR2 antagonist AZD5069 in bronchiectasis","volume":"46","author":"De Soyza","year":"2015","journal-title":"Eur. Respir. J."},{"issue":"23","key":"10.1016\/j.rmed.2026.109006_bib38","doi-asserted-by":"crossref","first-page":"24869","DOI":"10.1021\/acs.jmedchem.5c02638","article-title":"Design, synthesis, and biological evaluation of the novel neutrophil elastase inhibitor CHF-6333 for the inhaled treatment of bronchiectasis","volume":"68","author":"Armani","year":"2025","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.rmed.2026.109006_bib39","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1465-9921-14-137","article-title":"Inhibition of LPS-Induced airway neutrophilic inflammation in healthy volunteers with an oral CXCR2 antagonist","volume":"14","author":"Leaker","year":"2013","journal-title":"Respir. Res."},{"issue":"4","key":"10.1016\/j.rmed.2026.109006_bib40","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1183\/23120541.00583-2020","article-title":"CXCL-8-dependent and -independent neutrophil activation in COPD: experiences from a pilot study of the CXCR2 antagonist danirixin","volume":"6","author":"Keir","year":"2020","journal-title":"ERJ Open Res"},{"issue":"2","key":"10.1016\/j.rmed.2026.109006_bib41","first-page":"111","article-title":"A randomised, placebo-controlled, dose-finding study of AZD9668, an oral inhibitor of neutrophil elastase, in patients with chronic obstructive pulmonary disease treated with tiotropium","volume":"9","author":"Vogelmeier","year":"2012","journal-title":"COPD J. Chronic Obstr. Pulm. Dis."},{"issue":"1","key":"10.1016\/j.rmed.2026.109006_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(02)02182-9","article-title":"The role of neutrophil elastase in acute lung injury","volume":"451","author":"Kawabata","year":"2002","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.rmed.2026.109006_bib43","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1136\/thx.48.5.560","article-title":"New perspectives on basic mechanisms in lung disease. 6. Proteinase imbalance: its role in lung disease","volume":"48","author":"Tetley","year":"1993","journal-title":"Thorax"},{"issue":"7","key":"10.1016\/j.rmed.2026.109006_bib44","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1183\/13993003\/erj.9.7.1482","article-title":"MR889, a neutrophil elastase inhibitor, in patients with chronic obstructive pulmonary disease: a double-blind, randomized, placebo-controlled clinical trial","volume":"9","author":"Luisetti","year":"1996","journal-title":"Eur. Respir. J."},{"issue":"5 Suppl","key":"10.1016\/j.rmed.2026.109006_bib45","doi-asserted-by":"crossref","first-page":"151S","DOI":"10.1378\/chest.121.5_suppl.151S","article-title":"Neutrophils and the pathogenesis of COPD","volume":"121","author":"Stockley","year":"2002","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.rmed.2026.109006_bib46","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jaci.2016.05.011","article-title":"Inflammatory mechanisms in patients with chronic obstructive pulmonary disease","volume":"138","author":"Barnes","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"issue":"16","key":"10.1016\/j.rmed.2026.109006_bib47","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1056\/NEJMoa2411664","article-title":"Phase 3 trial of the DPP-1 inhibitor brensocatib in bronchiectasis","volume":"392","author":"Chalmers","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2026.109006_bib48","unstructured":"Boehringer Ingelheim. BI 1291583 Investigator's Brochure\/Clinical Pharmacology Summary. Data on file."},{"issue":"8","key":"10.1016\/j.rmed.2026.109006_bib49","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1002\/bcp.70027","article-title":"Safety, tolerability, pharmacokinetics and pharmacodynamics of HSK31858, a novel oral dipeptidyl peptidase-1 inhibitor, in healthy volunteers: an integrated phase 1, randomized, double-blind, placebo-controlled, single- and multiple-ascending dose study","volume":"91","author":"Wang","year":"2025","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.rmed.2026.109006_bib50","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S2213-2600(25)00019-0","article-title":"Effects of the DPP-1 inhibitor HSK31858 in adults with bronchiectasis in China (SAVE-BE): a phase 2, multicentre, double-blind, randomised, placebo-controlled trial","volume":"13","author":"Zhong","year":"2025","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.rmed.2026.109006_bib53","unstructured":"Brinsupri | European Medicines Agency (EMA). European Medicines Agency (EMA). Published December 4, 2025. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/brinsupri."},{"issue":"1","key":"10.1016\/j.rmed.2026.109006_bib55","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1038\/s41598-022-09241-6","article-title":"The pan-JAK inhibitor LAS194046 reduces neutrophil activation from severe asthma and COPD patients in vitro","volume":"12","author":"Milara","year":"2022","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.rmed.2026.109006_bib54","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1517\/13543784.11.7.965","article-title":"Neutrophil elastase inhibitors as treatment for COPD","volume":"11","author":"Ohbayashi","year":"2002","journal-title":"Expert Opin. Invest. Drugs"},{"issue":"10","key":"10.1016\/j.rmed.2026.109006_bib56","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.clinthera.2025.08.011","article-title":"BRINSUPRI (Brensocatib)","volume":"47","author":"Beninger","year":"2025","journal-title":"Clin. Ther."},{"key":"10.1016\/j.rmed.2026.109006_bib57","series-title":"Astrazeneca. Brensocatib Investigator's Brochure\/Clinical Pharmacology Summary","year":"2023"},{"key":"10.1016\/j.rmed.2026.109006_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.657329","article-title":"NK cells and PMN-MDSCs in the graft from G-CSF mobilized haploidentical donors display distinct gene expression profiles from those of the non-mobilized counterpart","volume":"12","author":"Pelosi","year":"2021","journal-title":"Front. Immunol."},{"issue":"11 Apr","key":"10.1016\/j.rmed.2026.109006_bib60","article-title":"Tackling neutrophilic inflammation in bronchiectasis: from macrolides to cathepsin C inhibitors","volume":"19","author":"Gramegna","year":"2026","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.rmed.2026.109006_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1239151","article-title":"Dipeptidyl peptidase 1 inhibition as a potential therapeutic approach in neutrophil-mediated inflammatory disease","volume":"14","author":"Chalmers","year":"2023","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.rmed.2026.109006_bib62","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01126-2025","article-title":"European respiratory society clinical practice guideline for the management of adult bronchiectasis","volume":"66","author":"Chalmers","year":"2025","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2026.109006_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.803014","article-title":"Polymorphonuclear myeloid-derived suppressor cells are abundant in peripheral blood of cancer patients and suppress natural killer cell anti-tumor activity","volume":"12","author":"Tumino","year":"2022","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.rmed.2026.109006_bib64","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/s41375-019-0585-7","article-title":"PMN-MDSC are a new target to rescue graft-versus-leukemia activity of NK cells in haplo-HSC transplantation","volume":"34","author":"Tumino","year":"2020","journal-title":"Leukemia"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126003744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126003744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:43:59Z","timestamp":1793375039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611126003744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":60,"alternative-id":["S0954611126003744"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2026.109006","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the neutrophil\u2013DPP-1\u2013protease axis in airway disease: current evidence and future indications","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2026.109006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109006"}}